Bright Gene

IPO

Research-driven biopharmaceutical innovation from Suzhou

Public · Suzhou, China · Founded 2001 · $79.7M raised

Headquarters
Suzhou
Founded
2001
Business Model
B2B
Total Funding
$79.7M
Last Round
$79.7M Venture RoundJan 2019
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

BrightGene Bio-Medical Technology Co., Ltd. is a research-driven biopharmaceutical company headquartered in the Suzhou Industrial Park, China, focused on developing innovative treatments for oncology, infectious diseases, and metabolic conditions. The company conducts original drug discovery and clinical development, including a GLP1/GIP dual agonist that successfully completed Phase II clinical trials — a first in China. BrightGene also partners with global pharmaceutical and biotech organizations to expand access to medicines, including collaboration with the Medicines Patent Pool to manufacture generic formulations. With subsidiaries across multiple Chinese provinces, the company operates across both innovative drug R&D and commercial-scale pharmaceutical manufacturing.

Summary

Bright Gene is a Biotech company based in Suzhou, China, founded in 2001. It has raised $79.7M in total across 1 round, most recently a $79.7M Venture Round in Jan 2019. Investors include HighLight Capital and Sequoia Capital.

Funding & Exit History

IPONov 2019

Sign up to see all 2 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Bright Gene on Indexed.vc
<a href="https://indexed.vc/companies/bright-gene"><img src="https://indexed.vc/api/badge/company/bright-gene" alt="Bright Gene on Indexed.vc" width="260" height="76" /></a>